These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18634374)

  • 21. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis.
    Liao CT; Chen YM; Shiao CC; Hu FC; Huang JW; Kao TW; Chuang HF; Hung KY; Wu KD; Tsai TJ
    Nephrol Dial Transplant; 2009 Sep; 24(9):2909-14. PubMed ID: 19225016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual renal function and volume status in peritoneal dialysis patients: a conflict of interest?
    Van Biesen W; Lameire N; Verbeke F; Vanholder R
    J Nephrol; 2008; 21(3):299-304. PubMed ID: 18587717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery of renal function in end-stage renal failure--comparison between peritoneal dialysis and haemodialysis.
    Macdonald JA; McDonald SP; Hawley CM; Rosman J; Brown F; Wiggins KJ; Bannister K; Johnson DW
    Nephrol Dial Transplant; 2009 Sep; 24(9):2825-31. PubMed ID: 19443649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular issues in dialysis patients: challenges and newer insights.
    Guzon OJ; Dellsperger KC
    Adv Perit Dial; 2006; 22():111-5. PubMed ID: 16983952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
    Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
    J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of glucose homeostasis on protein metabolism in patients with advanced chronic kidney disease.
    Ikizler TA
    J Ren Nutr; 2007 Jan; 17(1):13-6. PubMed ID: 17198926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The behavior of protein and glucose levels in the blood and the dialyzing fluid during peritoneal dialysis in patients with renal failure.
    Bromberg-Sznek S; Lyczewska J; Vertun B
    Pol Med J; 1967; 6(3):556-62. PubMed ID: 6038077
    [No Abstract]   [Full Text] [Related]  

  • 30. Predictors of residual renal function loss in peritoneal dialysis: is previous renal transplantation a risk factor?
    Bernardo A; Fonseca I; Rodrigues A; Carvalho MJ; Cabrita A
    Adv Perit Dial; 2009; 25():110-4. PubMed ID: 19886330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis.
    Van Biesen W; Verbeke F; Vanholder R
    Nephrol Dial Transplant; 2007 Jan; 22(1):53-8. PubMed ID: 17050633
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of nutritional status, body composition, inflammation and serum iron on the developement of insulin resistance among patients on long-term hemodialysis.
    Rasić-Milutinović Z; Perunicić G; Pljesa S; Gluvić Z; Ilić M; Stokić E
    Med Pregl; 2007; 60 Suppl 2():33-8. PubMed ID: 18928154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does coronary artery calcification in patients with diabetic nephropathy depend on the advancement of renal failure?
    Krzanowski M; Kuśnierz-Cabala B; Miarka P; Wójcik K; Stompór T; Sułowicz W
    Med Pregl; 2007; 60 Suppl 2():39-42. PubMed ID: 18928155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease.
    Lindblad YT; Axelsson J; Bárány P; Celsi G; Lindholm B; Qureshi AR; Carrea A; Canepa A
    Blood Purif; 2008; 26(6):518-25. PubMed ID: 18987465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypoadiponectinemia: a cardiovascular risk factor in uremia. A view from the evidence].
    Estrada PN; Bajo MA; del Peso G; Iglesias P; Díez JJ; Fernández-Reyes MJ; Grande C; Sánchez Hernández R; Selgas R
    Nefrologia; 2006; 26(6):653-7. PubMed ID: 17227241
    [No Abstract]   [Full Text] [Related]  

  • 36. [The behavior of blood insulin and glucose in diabetic nephropathy under CAPD].
    Thomae U; Kuhlmann H; Boos W; Herrmann M; Eberhard K
    Med Welt; 1980 Oct; 31(44):1599-601. PubMed ID: 7005589
    [No Abstract]   [Full Text] [Related]  

  • 37. [The patient with chronic renal failure].
    Schammann T; Schindler R
    Med Monatsschr Pharm; 2008 Nov; 31(11):417-26; quiz 427-8. PubMed ID: 19055161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy outcome in peritoneal dialysis patients transferred from haemodialysis.
    Liberek T; Renke M; Skonieczny B; Kotewicz K; Kowalewska J; Chmielewski M; Kot J; Lichodziejewska-Niemierko M; Rutkowski B
    Nephrol Dial Transplant; 2009 Sep; 24(9):2889-94. PubMed ID: 19342418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome.
    Bell M; Granath F; Schön S; Löfberg E; ; Ekbom A; Martling CR
    Crit Care Med; 2008 Oct; 36(10):2773-8. PubMed ID: 18766088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Peritoneal dialysis in cirrhotic patients].
    De Vecchi AF
    G Ital Nefrol; 2009; 26(2):215-24. PubMed ID: 19382077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.